STAASTAAR Surgical Company

$860M

Q3 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$80M+5.6% YoY

Gross Profit

$64M79.2% margin

Operating Income

$6M7.8% margin

Net Income

$5M6.0% margin

EPS (Diluted)

$0.10

QoQ Revenue Growth

-13.0%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$15M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$472M

Total Liabilities

$93M

Stockholders' Equity

$379M

Cash & Equivalents

$127M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$80M	$76M	+5.6%
Gross Profit	$64M	$60M	+5.3%
Operating Income	$6M	$14M	-54.1%
Net Income	$5M	$10M	-53.1%

Revenue Segments

Implantable Collamer Lenses

$81M100%

Cataract Intraocular Lenses

$221,0000%

STAA Q3 2023 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena